Neurodegeneration with brain iron accumulation: Clinical, radiographic and genetic heterogeneity and corresponding therapeutic options

Acta Neurologica Belgica

Volumn 107, Issue 1, 2007, Pages 26-31

  Clement, Frederik ^a,c   Devos, David ^a   Moreau, Caroline ^a   Coubes, Philippe ^b   Destee, Alain ^a   Defebvre, Luc ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b GUI DE CHAULIAC HOSPITAL   (France)

^c Department of Neuroradiology   (Belgium)

Author keywords

Deep brain stimulation; Dystonia; Iron; Neurodegeneration; Pantothenate kinase

Indexed keywords

ANTIPARKINSON AGENT; BACLOFEN; BOTULINUM TOXIN; BROMOCRIPTINE; IRON; LEVODOPA; PANTOTHENATE KINASE; PANTOTHENATE KINASE 2; TRIHEXYPHENIDYL; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BRAIN DEPTH STIMULATION; CASE REPORT; CHILDHOOD; CLINICAL FEATURE; DENTATE NUCLEUS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSTONIA; FEMALE; GENETIC HETEROGENEITY; GLOBUS PALLIDUS; HALLERVORDEN SPATZ DISEASE; HUMAN; IMAGE ANALYSIS; LOW DRUG DOSE; MALE; MUTATIONAL ANALYSIS; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARKINSONISM; RADIOGRAPHY; RED NUCLEUS; SIGNAL DETECTION; SUBSTANTIA NIGRA; SYMPTOMATOLOGY;

EID: 34248369426     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. CAROD-ARTAL F. J., VARGAS A. P., MARINHO P. B., FERNANDES-SILVA T. V., PORTUGAL D. Tourettism, hemiballism and juvenile Parkinsonism: expanding the clinical spectrum of the neurodegeneration associated to panothenate kinase deficiency (Hallervorden Spatz syndrome). Rev. Neuro., 2004, 38 : 327-31.
2. THOMAS M., HAYFLICK S. J., JANKOVIC J. Clinical Heterogeneity of Neurodegeneration With Brain Iron Accumulation (Hallervorden-Spatz Syndrome) and Pantothenate Kinase-Associated Neurodegeneration. Mov. Disord., 2004, 19 : 36-42.
3. HAYFLICK S. J. Unraveling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name. Curr. Opin. Pediatr., 2003, 15 : 572-7.
4. HALLERVORDEN J., SPATZ H. Eigenartige Erkrankung im extrapyramidalen System mit besonderer Beteiligung des Globus pallidus und der Substantia nigra: Ein Beitrag zu den Beziehungen zwischen diesen beiden Zentren. Z Ges Neurol Psychiat, 1922, 79 : 254-302.
5. WIGBOLDUS J. M., BRUYN G. W. Hallervorden-Spatz disease. In: VINKEN P. J., BRUYN G. W. (eds.). Handbook of clinical neurology: diseases of the basal ganglia, 1968, 6 : 604-631.
6. HAYFLICK S. J., WESTAWAY S. K., LEVINSON B. Genetic, Clinical, and Radiographic Delineation of Hallervorden-Spatz Syndrome. N. Engl. J. Med., 2003, 348 : 33-40.
7. HALLIDAY W. The nosology of Hallervorden-Spatz disease. J. Neurol. Sci., 1995, 134 : 88-91.
8. GRIMES D. A., LANG A. E., BERGERON C. Late adult chorea with typical pathology of Hallervorden-Spatz syndrome. J Neurol. Neurosurg. Psychiatry, 2000, 69 : 392-395.
9. RACETTE B. A., PERRY A., D'AVOSSA G., PERLMUTTER J. S. Late-onset neurodegeneration with brain iron accumulation type 1: Expanding the clinical spectrum. Mov. Disord., 2001, 16 : 1148-52.
10. JANK0VIC J., KIRKPATRICK J. B., BLOMQUIST K. A., LANGLAIS P. J., BIRD E. D. Late-onset Hallervorden-Spatz disease presenting as familial parkinsonism. Neurology, 1985, 2 : 227-34.
11. DOOLING E. C., SCHOENE W. C., RICHARDSON E. P. Hallervorden-Spatz syndrome. Arch. Neurol., 1974, 30 : 70-83.
12. WANG L. N., HUANG K. W., Liu Z. Y. Sporadic late-onset type of Hallervorden-Spatz disease presenting as parkinsonism in a Chinese patient. Chin. Med. J., 1990, 103 : 686-688.
13. SETHI K. D., ADAMS R. J., LORING D. W., GAMMAL T. Hallervorden-Spatz Syndrome: Clinical and Magnetic Resonance Imaging Correlations. Ann. Neurol., 1998, 24 : 692-694.
14. GALLUCCI M., CARDONA F., ARACHI M., SPLENDIANI A., BOZZAO A. et al. Follow-up MR studies in Hallervorden-Spatz disease. J. Comput. Assist. Tomogr., 1990, 14 : 118-20.
15. GORDON N. Pantothenate kinase-associated neuro-degeneration (Hallervorden-Spatz syndrome). Eur J. Paediatr. Neurol., 2002, 6 : 243-7.
16. SEIBEL M. O., DATE E. S., ZEINER H., SCHWARTZ M. Rehabilitation of patients with Hallervorden-Spatz syndrome. Arch. Phys. Med. Rehabil., 1993, 74 : 328-9.
17. DRESSLER D., WITTSTOCK M., BENECKE R. Botulinum toxin for treatment of jaw opening dystonia in Hallervorden-Spatz syndrome. Eur. Neurol., 2001, 45 : 287-8.
18. VERCUEIL L., KRACK P., POLLAK P. Results of deep brain stimulation for dystonia: A critical reappraisal. Mov. Disord., 2002, 17 (suppl 3) : S89-93.
19. COUBES P., CIF L., FERTIT H. Electrical stimulation of the globus pallidus internus in patients with primary generalized dystonia: long-term results. J. Neurosurg., 2004, 10 : 189-194.
20. KRAUSS J. K., LOHER T. J., WEIGEL R., CAPELLE H. H., WEBER S. Chronic stimulation of the globus pallidus internus for treatment of non-DYT 1 generalized dystonia and choreoathetosis: 2-year follow-up. J. Neurosurg., 2003, 98 : 785-92.
21. KUPSCH A., KUEHN A., KLAFFKE S. Deep brain stimulation in dystonia. J Neurol, 2003, 250 (suppl. 1) : 147-52.
22. KRAUSS J. K. Deep brain stimulation for dystonia in adults Overview and developments. Stereotact. Funct. Neurosurg., 2002, 78 : 168-82.
23. VOLKMANN J., BENECKE R. Deep brain stimulation for dystonia: patient selection and evaluation. Mov. Disord. Suppl., 2002, 3 : S112-5.
24. TODA H., HAMANI C., LOZANO A. Deep brain stimulation in the treatment of dyskinesia and dystonia. Neurosurg. Focus, 2004, 17 : E2.
25. ELTAHAWY H. A., SAINT-CYR J., GILADI N., LANG A. E., LOZANO A. M. Primary dystonia is more responsive than secondary dystonia to pallidal interventions: Outcome after pallidotomy or pallidal deep brain stimulation. Neurosurgery, 2004, 54 : 613-19.
26. CIF L., EL FERTIT H., VAYSSIERE N., HEMM S., HARDOUIN E. et al. Treatment of dystonic syndromes by chronic electrical stimulation of the internal globus pallidusi. J. Neurosurg. Sci., 2003, 47 : 52-5.
27. CASTELNAU P., CIF L., VALENTE E. M., VAYSSIERE N., HEMM S. et al. Pallidal stimulation improves pantothenate kinase-associated neurodegeneration. Ann. Neurol, 2005, 57 : 613-4.